Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05293730 · ClinicalTrials.gov registry record · NA
Trial of the Impact of the Electronic Frailty Integrated With Social Needs
A NA study of Aging, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 2,050
- Enrollment target
- 1
- Study location
NCT05293730: Completed NA study of Aging, sponsored by Wake Forest University Health Sciences.
NCT05293730 is a NA study of Aging that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 2,050 participants, roughly in line with the 2,187-participant average among 262 other Aging trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05293730, a NA study of Aging, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,050 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants in Electronic Frailty Integrated with Social Needs (eFRIEND) will randomize to receive regularly scheduled in-person and telehealth contacts with a community health worker (CHW) or continue to receive standard of care. The purpose of this research is to use CHW to help older adults because there may be some resources that could benefit them that they are not aware of or for which they need help applying.
Primary Outcome
Healthcare encounters will be tracked using the Electronic Health Record (EHR)
Conditions Studied
Interventions
- OTHER Usual Care
- BEHAVIORAL eFRIEND
Study Locations (1)
North Carolina
- Atrium Health Wake Forest Baptist Health - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,050 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2024-05-12 |
| Phase | NA |
What the finished NCT05293730 record still lists
NCT05293730 is an interventional study that assigns participants to a tested intervention. Its 2,050 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,187-participant average among 262 other Aging trials with a reported enrollment target.
The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT05293730 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05293730 about?
NCT05293730 is a clinical study titled "Trial of the Impact of the Electronic Frailty Integrated With Social Needs". Participants in Electronic Frailty Integrated with Social Needs (eFRIEND) will randomize to receive regularly scheduled in-person and telehealth contacts with a community health worker (CHW) or continue to receive standard of care. The purpose of this research is to use CHW to help older adults beca...
What is the current status of trial NCT05293730?
This trial is currently completed. It is a NA study. The enrollment target is 2,050 participants. The study started on 2022-09-06. Estimated completion is 2024-05-12.
What conditions does trial NCT05293730 study?
This clinical trial studies the following conditions: Aging.
What interventions are being tested in trial NCT05293730?
The interventions under investigation include: Usual Care (OTHER), eFRIEND (BEHAVIORAL).
Who is sponsoring clinical trial NCT05293730?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05293730 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05293730's enrollment target sits among peer trials
2,050 9th of 262 higher than 254 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05050084 · 2,050 participants · Phase 3
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
- NCT05688982 · 2,049 participants · NA
MOLAR: Mapping Oral Health and Local Area Resources
- NCT06833476 · 2,044 participants
TTVR STRONG Under Coverage With Evidence Development (CED) Study
- NCT05138718 · 2,041 participants
FDG an Myocardial Infarction: The PIAF Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI